Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:05:24.879Z.
Calculation as of: 2026-10-06T12:05:24.879Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dce8aa4241063aa413a511fcc73ca02083e5b5875564fe7763a0d28183f25b54
EARNINGS YIELD
N/A
Market Cap
$245.65M
Earnings Yield
N/A
TTM Avg
37.01%
3Y Avg
37.01%
5Y Avg
37.01%
Market Cap
$248.21M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$251.64M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.30M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.05M
Earnings Yield
N/A
TTM Avg
1.20%
3Y Avg
4.13%
5Y Avg
3.97%
Market Cap
$264.10M
Earnings Yield
N/A
TTM Avg
6.60%
3Y Avg
6.60%
5Y Avg
6.49%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | $244.25M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | N/A | 37.01% | 37.01% | 37.01% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | N/A | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $239.45M | N/A | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $251.64M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $236.56M | N/A | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $264.05M | N/A | 1.20% | 4.13% | 3.97% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $264.10M | N/A | 6.60% | 6.60% | 6.49% |
| Alector, Inc. (ALEC)vs › | $220.94M | N/A | 3.98% | 3.98% | 3.98% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
